Reviewing the Appropriateness of Cross-Shareholdings and Selling Certain Holdings
First written in FY2020. 6 of 7 entries say "Advanced", first in FY2021. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Following the review, we sold securities that we determined did not necessarily have sufficient strategic significance to hold.」
The Group continued its qualitative and quantitative review of each individual strategically held stock. During the fiscal year, holdings decreased through the cancellation of 3 unlisted stocks, and 2 listed stocks were sold. - FY2025AdvancedAnnual report
「Following the review, we sold securities that we determined did not necessarily have sufficient strategic significance to hold.」
The company continued qualitative and quantitative verification of all strategically held shares. During the fiscal year, it sold 2 listed holdings while acquiring 2 unlisted holdings to strengthen business collaboration. - FY2024AdvancedAnnual report
「The Board of Directors' review during the fiscal year assessed the qualitative rationale for holding each individual stock and conducted quantitative assessments, including comparisons of total shareholder return and cost of capital. The review confirmed the rationale for holding all stocks.」
The Company conducted qualitative and quantitative reviews of all strategically held shares and sold 2 unlisted shareholdings during the current fiscal year. - FY2023AdvancedAnnual report
「The Board of Directors' review during the fiscal year consisted of confirming the qualitative rationale for holding each individual security and conducting quantitative reviews, including comparisons of total shareholder return and cost of capital. As a result of the review, securities judged not necessarily to have sufficient holding rationale were sold in the fiscal year ended March 2023.」
For cross-shareholdings, the company conducted qualitative and quantitative reviews of every individual holding and sold 1 unlisted holding and 2 listed holdings in the fiscal year ended March 2023. - FY2022AdvancedAnnual report
「Following a review, we sold in the fiscal year ending March 2022 certain securities that we determined did not necessarily have sufficient strategic value to hold. We also donated some securities to Shimadzu Gakuen Educational Foundation.」
Regarding cross-shareholdings, the company reviewed the rationale for holdings in the fiscal year ended March 2022 and disclosed decreases of 2 unlisted securities and 8 listed securities, as well as partial donations to the Shimadzu Gakuen educational corporation. - FY2021AdvancedAnnual report
「The Board of Directors' review during the fiscal year involved confirming the qualitative rationale for holding each individual security and conducting quantitative reviews, including comparisons of total shareholder return and cost of capital. As a result of the review, securities judged not necessarily to have sufficient holding rationale were sold in the fiscal year ending March 2021.」
For cross-held shares, we conducted qualitative and quantitative reviews of individual holdings, sold 6 holdings in the fiscal year ended March 2021, and donated some holdings to a foundation. - FY2020First statedAnnual report
「Each year, the Board of Directors verifies that the scale of cross-shareholdings is not inappropriate and reviews each individual holding to determine whether it remains appropriate in light of its purpose and whether the benefits and risks of holding it are commensurate with the cost of capital and other factors. Based on this review, we sold certain holdings in the fiscal year ended March 2020 that were judged not necessarily to have sufficient strategic significance.」
First detailed disclosure of the annual Board review of cross-shareholdings against their purpose, benefits, risks, and cost of capital, and the sale of certain holdings in the fiscal year ended March 2020.